NorthWest Biotherapeutics Inc (NWBO)

[HyGro]

NWBO has repeatedly reported confounding of trial data -- FACT. NWBO tossed out the original primary endpoint - FACT. NWOB manipulated the trial with new protocol, comparator. endpoints and SAP -- FACT. Recurrent OS was a post hoc data dredged endpoint -- FACT. FDA put a partial hold on the NWBO trial -- FACT.

Deny it all you want -- these are all company reported facts in their SEC 10K filings filed under penalty of perjury.